Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm acrosome-associated protein 5B (SPACA5B) is a member of the lysozyme-like family specifically expressed in sperm, where it is predicted to localize to the acrosome and sperm flagellum[3]. It is thought to play a role in sperm-egg membrane fusion during fertilization and may have lysozyme-related activity, though likely without traditional bacteriolytic function. SPACA5B is closely related to SPACA5 and LYZL family proteins, which are involved in the structural and functional integrity of the acrosome, essential for successful fertilization[3]. No therapeutics currently target this protein, and it is not considered a mainstream therapeutic target, but defects or mutations could potentially contribute to infertility phenotypes. No significant safety or biomarker utility currently exists for this protein.
Not applicable (no known drugs interact with or target SPACA5B)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm acrosome-associated protein 5B (SPACA5B).